Please assess the completion status of the following clinical trial:

Trial Title: Fecal Microbiota Transplantation (FMT) in the Management of Ulcerative Colitis (UC)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with biopsy proven ulcerative colitis (UC), including those with inadequately controlled UC (flare) as defined by failure of standard medical therapy, steroid-dependence, and/or need for escalation of medical care as determined by severity index (Mayo Score), endoscopic or histologic study, and/or medical provider~* Have active disease, defined with a Mayo Score \> 3 and Mayo endoscopic subscore \>1~* Subjects whom the investigator believes can and will comply with the requirements of the protocol~* Able to provide informed written consent.~Exclusion Criteria:~* Biopsy-proven Crohn's disease or indeterminate colitis~* Acute abdomen or other clinical emergencies requiring emergent management (for example: stricture, bowel obstruction, perforation and/or abscess)~* Primary sclerosing cholangitis (PSC)~* Pregnancy~* Concurrent Clostridium difficile infection or other known infection~* Prior history of fecal microbiota transplantation~* Other causes of diarrhea, including but not limited to tube feeds and medications (for example, kayaxelate, metformin, lactulose, laxatives, magnesium)~* Major congenital defects~* Subjects with recent malignancy in the last 5 years, excluding non-melanoma skin malignancies~* Anaphylactic reactions to any foods~* Any antibiotic use within the last 3 months~* Subject having any other condition that, in the opinion of the investigator, would jeopardize the safety or rights of the participant participating in the study, would make it unlikely for the participant to complete the study, or would confound the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Fecal Microbiota Transplantation (Type: EXPERIMENTAL): Individuals with Ulcerative Colitis will undergo a fecal microbiota transplantation.

Based on this trial design, predict the completion outcome and termination type (if applicable).